Drug Safety: Fasinumab Evaluated in Clinical Trials, Plus Celecoxib May Not Pose Increased Heart Attack or Stroke Risk
FDA Update: Committee Recommends 2 mg Baricitinib Approval; HLH Identified as Serious Adverse Event for Lamotrigine
FDA Staff Raises Safety Concerns Over Arthritis Drug Baricitinib
FDA to Review Abuse Deterrent Oxycodone Capsule & More
Dermatology Patients on Corticosteroids May Not Receive Osteoporosis Screenings; Plus FDA Approves ZTLido
Ferumoxytol Injection Receives New Indication, & Application for GP2017 Moves Ahead
FDA Receives Reports of Loperamide Abuse
Upadacitinib Receives Breakthrough Designation, Abatacept Use Expands in Australia & More
FDA Removes Boxed Warning for Combination Asthma Treatment
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- Next Page »